BCOR Internal Tandem Duplication Associated Uterine Sarcoma: Expanding the Clinicopathologic Spectrum

Int J Gynecol Pathol. 2022 Sep 1;41(5):503-507. doi: 10.1097/PGP.0000000000000822. Epub 2021 Aug 30.

Abstract

The diagnosis of high-grade endometrial stromal sarcoma has become more refined following molecular characterization of these tumors. Recently BCOR internal tandem duplications (ITD) have been identified in a small number of high-grade endometrial stromal sarcoma. Here we present an additional case of this rare entity in a young woman in her late teens. She presented with menorrhagia and underwent resection of 2 uterine lesions. The tumor was a spindle cell neoplasm composed of long fascicles with low to moderate cellularity, mild to moderate cytologic atypia, and up to 2 mitotic figures per 10 high power fields. Necrosis was not identified. Immunohistochemical stains showed the tumor to be positive for cyclin D1 in >50% of tumor cells, focally positive for CD10, and negative for SMA, desmin, h-caldesmon, and ALK1. BCOR ITD was confirmed by polymerase chain reaction with subsequent Sanger sequencing. Clues to the diagnosis of BCOR ITD uterine sarcoma include young patient age, uniform nuclear features, and diffuse positivity for cyclin D1. These features should prompt further molecular interrogation for definitive diagnosis, which is important for prognostication.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / genetics
  • Cyclin D1
  • Endometrial Neoplasms* / pathology
  • Female
  • Humans
  • Proto-Oncogene Proteins / genetics
  • Repressor Proteins / genetics
  • Sarcoma, Endometrial Stromal* / diagnosis
  • Sarcoma, Endometrial Stromal* / genetics
  • Uterine Neoplasms* / diagnosis
  • Uterine Neoplasms* / genetics

Substances

  • BCOR protein, human
  • Biomarkers, Tumor
  • Proto-Oncogene Proteins
  • Repressor Proteins
  • Cyclin D1